The U.S. Food and Drug Administration is examining a potential link between the diabetes drug Actos or pioglitazone and an increased risk of bladder cancer. Patients who have taken this medication to help control their type 2 diabetes for more than two years have an elevated risk of developing cancer of the bladder, but the FDA did not announce how great this risk might be. They have not gone so far as to tell doctors to stop prescribing it or recommending that patients stop taking it.
Learn more about the symptoms and causes of diabetes mellitus and natural diabetes treatment options.
